Updates in SMA and Gene Therapy from Arlington, VA: March 2018 – MedPage Today
|
Updates in SMA and Gene Therapy from Arlington, VA: March 2018
MedPage Today Even among those who may be aware of SMA, there is an overall clinician tendency to delay evaluating/addressing potential neuromotor deficits. Many clinicians have a suboptimal understanding of the genetic aspect of the disease, and, in addition, few … |
